References
- Harris MI. Summary. In: National Diabetes Data Group. Diabetes in America. 2d ed. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:1–13; NIH publication No. 95–1468
- Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78(4):809A–809F
- Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328(23):1676–85
- Ross MA. Neuropathies associated with diabetes. Med Clin North Am 1993; 77(1): 111–24
- Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977–86
- Trevisan R, Viberti G. Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 1995; 126(4):342–9
- American Diabetes Association. Diabetic nephropathy. Diabetes Care 1997; 20(Suppl l):S24–7
- Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329(20):1456–62 [Erratum, N Engl J Med 1993; 330(2):152]
- Ravid M, Savin H, Jutrin I, et al. Long-term stabilizing effect of angiotensin- converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118(8):577–81
- Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992, 15(2): 159–65
- Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331(13):854–60
- Midodrine Study Group. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, doubleblind multicenter study. JAMA 1997; 277(13):1046–51